Head-to-head
Remedy Meds vs MEDVi
Compared on both medications across the eight dimensions this database records. They differ on 0 of those eight. Remedy Meds is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Remedy Meds is $399 a month all-in for tirzepatide; MEDVi is $399. Over twelve months that is $4,788 against $4,788. Value Scores are 57.4 and 57.4 out of 100.
Tirzepatide
Plan pages: Remedy Meds plans · MEDVi plans
At 10 mg/week, Remedy Meds is $399 a month all-in and MEDVi is $399, identical figures. Over twelve months the totals are $4,788 (billed monthly) and $4,788 (billed monthly).
Remedy Meds charges a flat $399 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
MEDVi charges a flat $399 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
| Dose | Remedy Meds | Rank | MEDVi | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $399 | 28/31 | $399 | 27/31 | level |
| 5 mg | $399 | 16/17 | $399 | 15/17 | level |
| 7.5 mg | $399 | 15/17 | $399 | 14/17 | level |
| 10 mg | $399 | 22/27 | $399 | 21/27 | level |
| 12.5 mg | $399 | 15/17 | $399 | 14/17 | level |
| 15 mg | $399 | 15/17 | $399 | 14/17 | level |
Remedy Meds is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, Remedy Meds sits 20 of 27 on all-in monthly cost and MEDVi sits 21. They are adjacent in the field, with nothing priced between them. The field median is $339 and the floor is $169, so both sit above the median. Remedy Meds is $230 above the cheapest tirzepatide program on record. MEDVi is $230 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Remedy Meds undercuts it by $50, MEDVi by $50. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Remedy Meds | MEDVi | Cheaper |
|---|---|---|---|
| Month to month | $399 | $399 | level |
| Settled dose | Remedy Meds | MEDVi | Difference |
|---|---|---|---|
| 2.5 mg | $4,788 | $4,788 | $0 apart |
| 5 mg | $4,788 | $4,788 | $0 apart |
| 7.5 mg | $4,788 | $4,788 | $0 apart |
| 10 mg | $4,788 | $4,788 | $0 apart |
| 12.5 mg | $4,788 | $4,788 | $0 apart |
| 15 mg | $4,788 | $4,788 | $0 apart |
Remedy Meds publishes no rate for 3-month term, 6-month term, 12-month term; MEDVi publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $4,788 on Remedy Meds and $4,788 on MEDVi. Both programs charge one flat rate, so the ramp costs the same as any other stretch of the year.
Value Scores are 57.4 for Remedy Meds and 57.4 for MEDVi, against a tirzepatide category floor of $169. Remedy Meds leads by 0.0 points, and the margin comes from structure rather than price alone.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Remedy Meds | 29.6 | 12.8 | 10 | 5 | 57.4 |
| MEDVi | 29.6 | 12.8 | 10 | 5 | 57.4 |
Semaglutide
Plan pages: Remedy Meds plans · MEDVi plans
At 2.4 mg/week, Remedy Meds is $299 a month all-in and MEDVi is $299, identical figures. Over twelve months the totals are $3,588 (billed monthly) and $3,588 (billed monthly).
Remedy Meds charges a flat $299 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
MEDVi charges a flat $299 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Remedy Meds is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 58.0 for Remedy Meds and 58.0 for MEDVi, against a semaglutide category floor of $129. Remedy Meds leads by 0.0 points, and the margin comes from structure rather than price alone.
Where the two programs differ
All-in monthly
Both programs land at the same all-in monthly figure of $399, so price alone does not separate them and the decision moves to structure.
Cancellation terms
Both state the same cancellation terms: Cancel before renewal.
Commitment
Commitment terms read the same on both: Month-to-month.
Dose policy
Both hold one price across the whole dose ladder, so neither punishes titration and the monthly figures above are what you actually pay at 15 mg as well as at 2.5 mg.
Evidence status
Both figures carry the same evidence status, provider-stated: taken from the provider's own published pages; checkout capture pending. Neither is stronger than the other on provenance.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
Twelve-month cost
Over twelve months the totals are $4,788 for Remedy Meds and $4,788 for MEDVi. MEDVi is lower by $0 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
What each record says
Remedy Meds Official site
Remedy sells flat-price programs at $299/month semaglutide and $399/month tirzepatide — simple structure, upper-half pricing.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — remedymeds.com pricing capture 2026-08-05
Watch: Provider-stated; checkout capture pending.
MEDVi Official site
MEDVi advertises a $179 semaglutide start that tiers to $299 at maintenance; tirzepatide is $399 flat.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — medvi.com pricing capture 2026-08-05
Watch: Start-vs-maintenance spread on semaglutide; compare on maintenance.
What neither record tells you
Remedy Meds does not publish
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Most US states
MEDVi does not publish
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Most US states
Ask Remedy Meds and MEDVi for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Neither program publishes a promotional rate with an end date, a prepaid term, or a price we have flagged for re-verification, so the comparison above is as stable as this dataset gets.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, Remedy Meds Official site wins this matchup. On the structural dimensions the two are close enough that the choice comes down to availability in your state and which intake you prefer.
Both figures should be checked at the provider's own checkout before you pay. Remedy Meds's tirzepatide price is provider-stated as of 2026-08-05; MEDVi's is provider-stated as of 2026-08-05.
Questions
Is Remedy Meds or MEDVi cheaper for tirzepatide?
Remedy Meds is cheaper on all-in monthly cost at 10 mg/week: $399 against $399, a difference of $0 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Remedy Meds versus MEDVi?
Remedy Meds works out to $4,788 across twelve months and MEDVi to $4,788, on the plan terms each publishes.
Does Remedy Meds or MEDVi raise the price as the dose goes up?
Remedy Meds: no, it charges one flat rate at every dose. MEDVi: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Remedy Meds and MEDVi differ?
0 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Remedy Meds and MEDVi names its pharmacy?
Neither. Remedy Meds records Partner pharmacies and MEDVi records Partner pharmacies. Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the Remedy Meds and MEDVi prices?
Remedy Meds's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. MEDVi's is provider-stated, captured 2026-08-05. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
Remedy Meds, at $299 a month all-in against $299 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: Remedy Meds official site · MEDVi official site. Compounded tirzepatide and semaglutide are not FDA-approved products.